Unknown

Dataset Information

0

Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy.


ABSTRACT: The December 2019 outbreak of a novel respiratory virus, SARS-CoV-2, has become an ongoing global pandemic due in part to the challenge of identifying symptomatic, asymptomatic, and pre-symptomatic carriers of the virus. CRISPR diagnostics can augment gold-standard PCR-based testing if they can be made rapid, portable, and accurate. Here, we report the development of an amplification-free CRISPR-Cas13a assay for direct detection of SARS-CoV-2 from nasal swab RNA that can be read with a mobile phone microscope. The assay achieved ∼100 copies/μL sensitivity in under 30 min of measurement time and accurately detected pre-extracted RNA from a set of positive clinical samples in under 5 min. We combined crRNAs targeting SARS-CoV-2 RNA to improve sensitivity and specificity and directly quantified viral load using enzyme kinetics. Integrated with a reader device based on a mobile phone, this assay has the potential to enable rapid, low-cost, point-of-care screening for SARS-CoV-2.

SUBMITTER: Fozouni P 

PROVIDER: S-EPMC7834310 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8743278 | biostudies-literature
| S-EPMC8730380 | biostudies-literature
| S-EPMC8009180 | biostudies-literature
| S-EPMC8420437 | biostudies-literature
| S-EPMC8440162 | biostudies-literature
| S-EPMC7738867 | biostudies-literature
| S-EPMC5526198 | biostudies-literature
| S-EPMC6959245 | biostudies-literature
| S-EPMC7860141 | biostudies-literature
| S-EPMC7235268 | biostudies-literature